Anke Van der Perren Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences KU Leuven Biography Publications Institution JoVE Articles Anke Van der Perren has not added a biography. If you are Anke Van der Perren and would like to personalize this page please email our Author Liaison for assistance. Publications Noninvasive Imaging Reveals Stable Transgene Expression in Mouse Airways After Delivery of a Nonintegrating Recombinant Adeno-Associated Viral Vector Human Gene Therapy. Jan, 2016 | Pubmed ID: 26567984 Binocular Pattern Deprivation Interferes with the Expression of Proteins Involved in Primary Visual Cortex Maturation in the Cat Molecular Brain. 2015 | Pubmed ID: 26271461 Nigral Overexpression of Alpha-synuclein in the Absence of Parkin Enhances Alpha-synuclein Phosphorylation but Does Not Modulate Dopaminergic Neurodegeneration Molecular Neurodegeneration. 2015 | Pubmed ID: 26099628 Nigral Proteasome Inhibition in Mice Leads to Motor and Non-motor Deficits and Increased Expression of Ser129 Phosphorylated α-synuclein Frontiers in Behavioral Neuroscience. 2015 | Pubmed ID: 25873870 FK506 Reduces Neuroinflammation and Dopaminergic Neurodegeneration in an α-synuclein-based Rat Model for Parkinson's Disease Neurobiology of Aging. Mar, 2015 | Pubmed ID: 25660193 Viral Vector-based Models of Parkinson's Disease Current Topics in Behavioral Neurosciences. 2015 | Pubmed ID: 24839101 Longitudinal Follow-up and Characterization of a Robust Rat Model for Parkinson's Disease Based on Overexpression of Alpha-synuclein with Adeno-associated Viral Vectors Neurobiology of Aging. Dec, 2014 | Pubmed ID: 25599874 Alpha-synuclein-induced Neurodegeneration is Exacerbated in PINK1 Knockout Mice Neurobiology of Aging. Nov, 2014 | Pubmed ID: 25037286 Long-term Overexpression of Human Wild-type and T240R Mutant Parkin in Rat Substantia Nigra Induces Progressive Dopaminergic Neurodegeneration Journal of Neuropathology and Experimental Neurology. Feb, 2014 | Pubmed ID: 24423640 RAAV2/7 Vector-mediated Overexpression of Alpha-synuclein in Mouse Substantia Nigra Induces Protein Aggregation and Progressive Dose-dependent Neurodegeneration Molecular Neurodegeneration. 2013 | Pubmed ID: 24267638 Endonuclease G Mediates α-synuclein Cytotoxicity During Parkinson's Disease The EMBO Journal. Nov, 2013 | Pubmed ID: 24129513 A Surgical Technique for Homogenous Renal Distribution of Substances in Rats European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes. 2013 | Pubmed ID: 24081026 Разработка альфа-синуклеина основе Rat модели для лечения болезни Паркинсона с помощью стереотаксической инъекции рекомбинантного аденосателлитные вирусного вектора Anke Van der Perren1, Cindy Casteels2, Koen Van Laere2, Rik Gijsbers3,4, Chris Van den Haute1,4, Veerle Baekelandt1 1Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, 2Division of Nuclear Medicine, Leuven University Hospital - KU Leuven, 3Laboratory for Molecular Virology and Gene Therapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 4Leuven Viral Vector Core, KU Leuven Medicine Новый хирургический подход к интратрахеального введения биологически активных веществ в фетальный модель мыши Marianne S. Carlon*1, Jaan Toelen*2, Marina Mori da Cunha2, Dragana Vidović1, Anke Van der Perren3, Steffi Mayer2, Lourenço Sbragia2, Johan Nuyts4, Uwe Himmelreich5, Zeger Debyser1, Jan Deprest2 1Molecular Virology and Gene Therapy, KU Leuven, 2Department of Woman and Child, KU Leuven, 3Neurobiology and Gene Therapy, KU Leuven, 4Division of Nuclear Medicine, KU Leuven, 5Biomedical NMR Unit/ MoSAIC, KU Leuven JoVE 4219 Medicine
Разработка альфа-синуклеина основе Rat модели для лечения болезни Паркинсона с помощью стереотаксической инъекции рекомбинантного аденосателлитные вирусного вектора Anke Van der Perren1, Cindy Casteels2, Koen Van Laere2, Rik Gijsbers3,4, Chris Van den Haute1,4, Veerle Baekelandt1 1Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, 2Division of Nuclear Medicine, Leuven University Hospital - KU Leuven, 3Laboratory for Molecular Virology and Gene Therapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 4Leuven Viral Vector Core, KU Leuven Medicine
Новый хирургический подход к интратрахеального введения биологически активных веществ в фетальный модель мыши Marianne S. Carlon*1, Jaan Toelen*2, Marina Mori da Cunha2, Dragana Vidović1, Anke Van der Perren3, Steffi Mayer2, Lourenço Sbragia2, Johan Nuyts4, Uwe Himmelreich5, Zeger Debyser1, Jan Deprest2 1Molecular Virology and Gene Therapy, KU Leuven, 2Department of Woman and Child, KU Leuven, 3Neurobiology and Gene Therapy, KU Leuven, 4Division of Nuclear Medicine, KU Leuven, 5Biomedical NMR Unit/ MoSAIC, KU Leuven JoVE 4219 Medicine
